G Kroemer
Overview
Explore the profile of G Kroemer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
352
Citations
26051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia L, Xu Z, Zhou X, Bergmann F, Grabe N, Buchler M, et al.
Cell Death Dis
. 2020 Oct;
11(10):889.
PMID: 33087696
Chronic pancreatitis (CP) is associated with elevated plasma levels of bacterial lipopolysaccharide (LPS) and we have demonstrated reduced acinar cell autophagy in human CP tissue. Therefore, we investigated the role...
2.
Elkrief A, Derosa L, Kroemer G, Zitvogel L, Routy B
Ann Oncol
. 2019 Jul;
30(10):1572-1579.
PMID: 31268133
Immune-checkpoint inhibitors (ICI) now represent the standard of care for several cancer types. In pre-clinical models, absence of an intact gut microbiome negatively impacted ICI efficacy and these findings permitted...
3.
Messaoudene M, Mourikis T, Michels J, Fu Y, Bonvalet M, Lacroix-Trikki M, et al.
Ann Oncol
. 2019 Mar;
30(6):934-944.
PMID: 30924846
Background: Tumor-infiltrating lymphocytes (TILs) represent a prognostic factor for survival in primary breast cancer (BC). Nonetheless, neoepitope load and TILs cytolytic activity are modest in BC, compromising the efficacy of...
4.
Soussi T, Kroemer G
Trends Cancer
. 2018 Aug;
4(9):602-605.
PMID: 30149877
Half of human cancers bear inactivating mutations of the tumor suppressor gene TP53, but the other half do not. In a recent issue of Cancer Cell, Dhar et al. and...
5.
Jacquelot N, Roberti M, Enot D, Rusakiewicz S, Ternes N, Jegou S, et al.
Nat Commun
. 2017 Sep;
8(1):592.
PMID: 28928380
Immune checkpoint blockers (ICB) have become pivotal therapies in the clinical armamentarium against metastatic melanoma (MMel). Given the frequency of immune related adverse events and increasing use of ICB, predictors...
6.
Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R, Zhivotovsky B
Oncogene
. 2017 Apr;
36(33):4818.
PMID: 28394341
This corrects the article DOI: 10.1038/sj.onc.1205018.
7.
Galluzzi L, Bravo-San Pedro J, Kroemer G
Methods Enzymol
. 2017 Mar;
587:xxiii-xxix.
PMID: 28253980
No abstract available.
8.
Bravo-San Pedro J, Pietrocola F, Sica V, Izzo V, Sauvat A, Kepp O, et al.
Methods Enzymol
. 2017 Mar;
587:71-86.
PMID: 28253977
Macroautophagy is a specific variant of autophagy that involves a dedicated double-membraned organelle commonly known as autophagosome. Various methods have been developed to quantify the size of the autophagosomal compartment,...
9.
Galluzzi L, Bravo-San Pedro J, Kroemer G
Methods Enzymol
. 2017 Feb;
588:xxv-xxxi.
PMID: 28237121
No abstract available.
10.
Sauvat A, Zhou H, Leduc M, Gomes-da-Silva L, Bezu L, Muller K, et al.
Methods Enzymol
. 2017 Feb;
588:219-230.
PMID: 28237103
Mitophagy is a peculiar form of organelle-specific autophagy that targets mitochondria. This process ensures cellular homeostasis, as it fosters the disposal of aged and damaged mitochondria that otherwise would be...